NASDAQ$PDSB

PDS Biotechnology Corporation · Q3 2019 earnings

Q3 2019 earnings · · Investor relations

Headline financials

EPS (adj)

-$1.10

Previous: -$2.80+60.7%
G&A Expenses

$3.07M

No prior period
R&D Expenses

$1.83M

No prior period

Revenue & EPS history

PDS Biotechnology · Revenue · Quarterly

$0

Q4 2026

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2019

Historical avgQ3 2019

+1.3%

Avg return

Earnings day

+2.0%

Avg return

5 days after

+2.0%

Avg return

30 days after

52%

22 / 42 earnings

Positive

+55.0%

Q3 2022

Best reaction

-27.2%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+0.1%+5.7%-3.8%
Q3 2025-12.2%-18.2%+1.0%
Q2 2025-4.9%+0.8%-5.7%
Q1 2025+4.8%+15.0%+37.8%
Q4 2024+0.8%-12.9%+0.8%
Q3 2024-27.2%-24.0%-33.2%
Q2 2024-1.0%+6.6%+0.0%
Q1 2024-0.3%-4.4%-21.2%
Q4 2023-11.6%-10.3%-27.0%
Q3 2023+20.3%+19.7%+2.9%
Q2 2023+21.2%+17.1%+13.2%
Q1 2023+5.0%+14.9%-7.4%
Q4 2022+2.2%-4.7%+1.0%
Q3 2022+55.0%+54.5%+64.3%
Q2 2022+0.2%+1.9%-21.7%
Q1 2022-14.3%+15.2%-21.7%
Q4 2021-1.1%-1.0%-12.1%
Q3 2021-1.6%+2.2%-14.6%
Q2 2021+0.6%-6.5%+44.5%
Q1 2021+8.2%+27.0%+174.1%
Q4 2020+1.9%-5.3%+2.3%
Q3 2020-0.5%-1.9%+3.8%
Q2 2020-5.1%+0.7%-26.5%
Q1 2020-2.3%-1.8%+39.3%
Q4 2019+2.3%-7.9%+29.6%
Q3 2019+0.0%-14.0%-3.4%
Q2 2019+1.1%-0.5%-15.2%
Q1 2019+43.0%+18.6%+6.4%
Q4 2018+3.8%+2.6%-1.7%
Q3 2018-2.8%-4.9%-6.2%
Q2 2018+1.3%+0.0%-4.3%
Q1 2018-6.4%-3.6%-15.3%
Q4 2017+1.5%+9.4%-92.2%
Q3 2017+1.2%-2.2%-8.0%
Q2 2017-1.2%-3.1%-2.0%
Q1 2017+2.8%+2.4%+3.2%
Q4 2016-9.5%-8.8%-7.1%
Q3 2016-6.3%-0.6%+9.9%
Q2 2016+1.9%+0.1%-4.6%
Q1 2016-4.2%
Q4 2015-14.2%
Q3 2015+0.5%
Q2 2015
Q1 2015
Q4 2014
Q3 2014

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro